← Back to Clinical Trials
Recruiting NCT06948916

NCT06948916 Validity and Reliability of 6-minute Pegboard and Ring Test in Patients With Interstitial Lung Disease

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06948916
Status Recruiting
Phase
Sponsor Gazi University
Condition Interstitial Lung Diseases (ILD)
Study Type OBSERVATIONAL
Enrollment 34 participants
Start Date 2024-12-12
Primary Completion 2025-07-12

Trial Parameters

Condition Interstitial Lung Diseases (ILD)
Sponsor Gazi University
Study Type OBSERVATIONAL
Phase N/A
Enrollment 34
Sex ALL
Min Age 18 Years
Max Age 75 Years
Start Date 2024-12-12
Completion 2025-07-12

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Interstitial lung diseases (ILD) are a heterogeneous group of chronic respiratory diseases that cause significant mortality and morbidity worldwide, characterized by diffuse inflammation in the lung parenchyma and vascular structures, can progress to fibrosis, have known or unknown etiology, and can develop secondary to systemic autoimmune connective tissue diseases other than diseases where the primary pathology is in the lung. The 6-minute peg-board and ring test, which was first developed to determine the upper extremity exercise capacity of chronic obstructive pulmonary disease patients, is an exercise test used to evaluate upper extremity functional exercise capacity in different lung diseases. It has been determined that there is no study on the validity and reliability of this test in individuals with ILD.

Eligibility Criteria

Inclusion Criteria: * Patients diagnosed with ILD according to ATS/ERS criteria, * Ages between 18 and 75, * Pulmonary infection during the previous month, * Participants who voluntarily participated in the study were included. Exclusion Criteria: * Patients were excluded if they had: * Acute pulmonary exacerbation or respiratory infection in the last four weeks * Obstructive lung disease * Systemic conditions affecting neurological, neuromuscular, orthopedic, or physical functions * Recent participation in a planned exercise program (within three months) * Cognitive impairment affecting exercise test understanding * Contraindications to exercise testing per the American Sports Medicine Association * Cancer, renal, or hepatic disease * Aortic stenosis, complex arrhythmia, or aortic aneurysm * Serious cardiovascular diseases like uncontrolled hypertension, diabetes, heart failure, or arrhythmia

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology